Now Available: Spotlight on Attovia CEO Tao Fu. Click here to read.
RedShiftBio has created a platform that combines microfluidic modulation spectroscopy (MMS) and quantum cascade lasers to generate precise, ultra-sensitive molecular structure measurements. “We are helping our customers see things they simply could not see before because it was too challenging or they didn't have the sensitivity or resolution,” said CEO Julien Bradley. “This technology opens ...
Illumina Ventures, a genomics and precision health focused venture firm, today announced additions to its investment team. Abhijit “Ron” Mazumder, PhD, MBA, joins as a Partner and Lisa Alderson, MBA as an Entrepreneur in Residence.
SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy, announced completion of its $60.75M Series A financing round.
“Fluent’s technology eliminates the need for complex, expensive instrumentation and microfluidic consumables,” said Wouter Meuleman, Partner at Illumina Ventures. “PIPseq is a simple, scalable workflow that can enable single cell sequencing in every lab for many applications while reducing costs and increasing accessibility.”
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
